Guardant Health Inc (GH) is a Healthcare · Diagnostics & Research company listed on NASDAQ. Price $177.95 (-2.81%), Market cap $12.68B, 52-week low–high $37.05 ~ $117.28.
Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy test for tumor mutation profiling; Guardant360 Liquid test, which measures 740+ genes and supports all guideline-recommended biomarkers; Guardant Reveal test, a blood test that utilizes circulating tumor DNA to detect cancer at the molecular level; and Guardant360 Tissue test, a molecular profiling test for tumor tissue that provides genomic, transcriptomic, and epigenomic insights. It also provides Shield blood test for colorectal cancer screening in adults. In addition, the company offers Guard
Financial statements, price targets, institutional (13F) holdings and related news for Guardant Health Inc are updated in real time on BlackAll Trade.
Guardant Health Inc trades at $177.95 (-2.81%). Real-time quotes and charts are available on BlackAll Trade.
Guardant Health Inc has a market cap of about $12.68B.
Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy t